TrueBlue, Inc. (TBI)

Investigation 

Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of Trueblue, Inc. (“Trueblue” or the “Company”) (NYSE: TBI). Investors who purchased Trueblue securities are encouraged to obtain additional information and assist the investigation.

 

The investigation concerns whether Trueblue and certain of its officers and/or directors have violated federal securities laws.


On June 15, 2022, TrueBlue issued a release “announc[ing] … that Patrick Beharelle has resigned as Chief Executive Officer and as a member of the Board of Directors of TrueBlue, effective June 14, 2022.” TrueBlue said that “Mr. Beharelle’s resignation follows an investigation, led by outside counsel, into allegations regarding his conduct. Based on the investigation’s findings, the Board of Directors determined that he had engaged in behaviors that violated TrueBlue’s policies and Code of Conduct. Mr. Beharelle’s conduct in question was not related to financial controls, financial statements, or business performance.” Following this news, TrueBlue stock dropped $1.06 per share, or 5%, to close at $18.55 on June 15, 2022.

If you are aware of any facts relating to this investigation or purchased Trueblue shares you can assist this investigation.  You can also contact Peretz Bronstein or his Investor Relations Analyst, Yael Nathanson of Bronstein, Gewirtz & Grossman, LLC: 212-697-6484. 

 

Bronstein, Gewirtz & Grossman, LLC represents investors in securities fraud class actions and shareholder derivative suits.  The firm has recovered hundreds of millions of dollars for investors nationwide.  Attorney advertising. Prior results do not guarantee similar outcomes.